Biotech Company Amgen Announces New Job Opportunities 

The Biotech Company Amgen opens new good-paying jobs that are coming to the already booming Wake County market. The company will build a new biologics manufacturing facility in Holly Springs, creating 355 jobs.

Cooper said that world-class companies like Amgen are very selective when they evaluate business locations, and they only choose places that provide the best support for their operations. The decision proves that North Carolina remains a premier location for the most innovative biotech companies in the industry.

Biotech Company Amgen plans to invest $550 million in Wake County. Wake County Board of Commissioners Chair Matt Calabria said that with Amgen’s reputation as one of the founding companies of the biotech revolution, it is a welcome addition to Wake County’s robust biotechnology sector. Biotech Company Amgen can expand anywhere in the world, but they continue to choose Wake County because our talented workforce, robust infrastructure and high quality of life are extremely attractive in today’s competitive marketplace. The company began in 1980 in Thousand Oaks, California, focuses on therapies for patients with serious illnesses such as cancer and heart disease.

It has grown to more than 24,000 employees worldwide, including more than 14,000 in the United States. The Holly Springs plant will be a biologics drug substance manufacturing plant. It is expected to begin operating in 2025. The pay for workers will differ based on job roles, but the aggregate average salary of the new positions is estimated at $119,510. The current average wage in Wake County is $63,966.Representative Gale Adcock said that Amgen is one of the world’s leading independent biotech companies. It is great to see Holly Springs and Wake County rise to the top as one of the premier locations for biomanufacturing in the world.